Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech company…
Source:Novel agent decreases neuropathic pain in patients with type 2 diabetes
Monday, December 15, 2014
Novel agent decreases neuropathic pain in patients with type 2 diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment